All News Archive — Page 98 of 151
-
April 1, 2024
Distinguished Vanderbilt alum to lead the NIH Fogarty International Center
Kathleen Neuzil, MD, MPH, a former faculty member and distinguished alumna of the Vanderbilt MPH Program, has been appointed director of the Fogarty International Center and associate director for international research at the National Institutes of Health. -
March 29, 2024
Anna Hemnes named director of the Division of Allergy, Pulmonary and Critical Care Medicine
Anna Hemnes, MD, has been named director of the Division of Allergy, Pulmonary and Critical Care Medicine, physician-in-chief of the Vanderbilt Lung Institute and director of the Center for Lung Research. -
March 29, 2024
What happens when musicians lose their hearing? Many find their way to VUMC’s Katie Berg — a scientist, a clinician — and a musician.
Cochlear implants can restore the ability to hear speech, but not music. In the heart of Music City, Katie Berg helps fit cochlear implants tuned specially for the needs of musicians. -
March 29, 2024
A gunshot to the head. A long recovery. Then a wedding.
Special Agent Adam Daniels celebrates ongoing recovery after gunshot causes traumatic brain injury; family’s gift will support care of others with similar injuries -
March 29, 2024
VUMC nurses lead Pearl-Cohn career fair to showcase health care careers to high school students
The fair featured a multidisciplinary group, including nursing, social work, EMS, pharmacy, medicine and surgical and radiology technologists. -
March 29, 2024
VUMC’s John Koethe named director of the Tennessee Center for AIDS Research
John Koethe, MD, MSCI, associate professor of Medicine in the Division of Infectious Diseases at Vanderbilt University Medical Center, has been appointed director and principal investigator of the Tennessee Center for AIDS Research. -
March 28, 2024
VUMC team discovers antibodies that may prevent severe respiratory illness
Using a technique developed at Vanderbilt University Medical Center, researchers identified antibodies that are excellent leads as potential therapies for human parainfluenza virus 3, a leading cause of acute and potentially fatal respiratory illness.